Sodium, Potassium, and Calcium channel alpha subunits

This grouping refers to the pore-forming alpha subunits of voltage-gated sodium, potassium, and calcium channels—integral membrane proteins that mediate selective, voltage-dependent transmembrane flux of Na⁺, K⁺, or Ca²⁺, respectively. Each subunit type is encoded by a separate gene family and contains a characteristic architecture of four homologous domains (sodium and calcium channels) or a tetramer of subunits (potassium channels), each with six transmembrane helices. These channels are essential for rapid electrical signaling in excitable tissues such as neurons and muscle. Many therapeutic drugs selectively target specific subtypes of these channels, and dysfunction of these subunits is implicated in a variety of channelopathies, including epilepsy, arrhythmia, and inherited pain disorders[1][2][3][4][5]. Due to encompassing multiple, unrelated protein families, "Sodium, Potassium, and Calcium channel alpha subunits" is not a precise canonical target name and is an incorrect entry for most structured pharmaceutical or molecular databases. Each channel family has multiple subtypes with distinct physiological and pharmacological properties.

Other names

Voltage-gated sodium channel alpha subunitVoltage-gated potassium channel alpha subunitVoltage-gated calcium channel alpha1 subunitNaV α subunitKV α subunitCaV α1 subunit

Blockade of channel pore to inhibit ion flux (e.g., sodium or calcium channel blockers); Modulation of channel gating or inactivation; Allosteric modulation affecting voltage sensitivity; Toxin binding (e.g., tetrodotoxin acting on sodium channels)